Label-free phenotypic antimicrobial susceptibility testing on microfluidic platforms: a review of advances and translation
Microchimica Acta · 2025
DOI: 10.1007/s00604-025-07662-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microchimica Acta, 2025. Verfasst von Muhammad Usman Abubakar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 211198, China. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Microfluidic Analytical Techniques, Lab-On-A-Chip Devices. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 141 Literaturangaben. Gefördert von: research project of Jiangsu Provincial Medical Key Discipline Cultivation Unit (JSDW202239).
Abstract (Originalsprache)
The escalating global threat of antimicrobial resistance (AMR) necessitates a paradigm shift towards rapid and scalable diagnostic technologies. Conventional antimicrobial susceptibility testing (AST) methods, while reliable, are hindered by prolonged turnaround times (often 16-24 h) and complex workflows, limiting their utility at the point-of-care (POC). Label-free phenotypic AST methods integrated within microfluidic platforms present a compelling alternative, enabling real-time, high-throughput monitoring of bacterial responses without the need for costly or time-consuming fluorescent labels and reagents. This review provides a comprehensive analysis and comparative evaluation of four primary label-free detection modalities: electrical impedance sensing, light scattering, surface-enhanced Raman spectroscopy (SERS), and machine vision powered by artificial intelligence (AI). We critically examine the principles of each technique, its integration with microfluidics, and its performance, highlighting studies that have demonstrated AST results in critically short timeframes (< 2-4 h) with high accuracy. Furthermore, we uniquely synthesize progress in commercial translation, discuss persistent challenges such as standardization and sample preparation, and provide a strengths, weaknesses, opportunities, and threats (SWOT) analysis to chart the future trajectory of the field. By offering a critical roadmap that bridges fundamental innovation with clinical application, this review demonstrates the potential of label-free microfluidic systems to deliver reagent-free, rapid, and scalable diagnostic solutions in the fight against AMR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 211198, China.
- Department of Laboratory Medicine, Nanjing First Hospital, China Pharmaceutical University, Nanjing, 210006, China.
- Department of Laboratory Medicine, Nanjing First Hospital, China Pharmaceutical University, Nanjing, 210006, China. mengqiuxiong@163.com.
- Department of Laboratory Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China. mengqiuxiong@163.com.
- Department of Clinical Pharmacy, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 211198, China. bhe@njmu.edu.cn.
- Department of Laboratory Medicine, Nanjing First Hospital, China Pharmaceutical University, Nanjing, 210006, China. bhe@njmu.edu.cn.
Förderung
- research project of Jiangsu Provincial Medical Key Discipline Cultivation Unit (JSDW202239)
Zitieren
APA
Abubakar, M. U., Abdullahi, S. H., Xiong, M., & He, B. (2025). Label-free phenotypic antimicrobial susceptibility testing on microfluidic platforms: a review of advances and translation. Microchimica Acta. https://doi.org/10.1007/s00604-025-07662-4
Vancouver
Abubakar MU, Abdullahi SH, Xiong M, He B. Label-free phenotypic antimicrobial susceptibility testing on microfluidic platforms: a review of advances and translation. Microchimica Acta. 2025. doi:10.1007/s00604-025-07662-4
BibTeX
@article{Abubakar2025,
author = {Abubakar, Muhammad Usman and Abdullahi, Suleiman Halima and Xiong, Mengqiu and He, Bangshun},
title = {Label-free phenotypic antimicrobial susceptibility testing on microfluidic platforms: a review of advances and translation},
journal = {Microchimica Acta},
year = {2025},
doi = {10.1007/s00604-025-07662-4}
}
EUVIMED